Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Rule 8.1- Synexus

19 Nov 2007 09:40

Sigma Acquisitions Limited19 November 2007 FORM 8.1 DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS (Rules 8.1(a) and (b)(i) of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) Sigma Acquisitions LimitedCompany dealt in Synexus Clinical Research plcClass of relevant security to which thedealings being disclosed relate (Note 2) 10p ordinary sharesDate of dealing 16 November 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class ofrelevant security dealt in (Note 3) Long Short Number Number (%) (%) (1) Relevant securities 1,802,914 (7.79%) (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 1,802,914 (7.79%) (b) Interests and short positions in relevant securities of the company,other than the class dealt in (Note 3) Class of relevant security: Long Short Number Number (%) (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Purchase 150,000 78p (b) Derivatives transactions (other than options) Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 7) price European etc. date paid/received per unit (Note 5) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. None Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 19 November 2007Contact name Mike BellTelephone number 020 7007 1463Name of offeree/offeror with which associated Sigma Acquisitions LimitedSpecify category and nature of associate status (Note 10) Adviser Notes The Notes on Form 8.1 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st Nov 20198:42 amRNSChange of Registered Office
5th Nov 20198:51 amRNSHolding(s) in Company
30th Oct 201911:06 amRNSSecond Price Monitoring Extn
30th Oct 201911:00 amRNSPrice Monitoring Extension
30th Oct 20197:00 amRNSTrading Update
2nd Oct 20194:12 pmRNSDirector/PDMR Shareholding
23rd Jul 20198:31 amRNSContract Win
23rd Jul 20197:00 amRNSHalf-year Report
21st Jun 20198:16 amRNSNotification of Interim Results
17th Jun 20199:53 amRNSHolding(s) in Company
13th Jun 20198:36 amRNSChange of Adviser
4th Jun 20191:41 pmRNSHolding(s) in Company
23rd May 201912:45 pmRNSDirector/PDMR Shareholding
25th Apr 20197:40 amRNSAGM Statement
24th Apr 20191:00 pmRNSDirector/PDMR Shareholding
27th Mar 20198:32 amRNSExercise of Options and Director/PDMR dealings
26th Mar 20197:00 amRNSContract Win in Gaming Sector
25th Mar 201910:01 amRNSDirectorate Change
21st Mar 201912:09 pmRNSAnnual Report and AGM
21st Mar 20197:00 amRNSOil & Gas Contract Win
8th Mar 20193:59 pmRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
25th Feb 20193:17 pmRNSHolding(s) in Company
19th Feb 20193:48 pmRNSDirectorate Update
29th Jan 20197:00 amRNSNotification of Final Results
29th Nov 20187:00 amRNSTrading Update
27th Nov 201811:29 amRNSDirector/PDMR Shareholding
29th Oct 201810:04 amRNSDirector/PDMR Shareholding
5th Oct 20187:00 amRNSDirector/PDMR Shareholding
25th Sep 20187:00 amRNSDirectorate Change
28th Aug 20187:00 amRNSSynectics secures UK custodial sites
14th Aug 20184:00 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSInterim Results
27th Jun 20187:00 amRNSNotification of Interim Results
1st Jun 20187:00 amRNSDirectorate Change
30th May 20183:23 pmRNSHolding(s) in Company
23rd May 20187:00 amRNSContract Win
11th May 20183:38 pmRNSDirector/PDMR Shareholding
27th Apr 201811:42 amRNSDirector/PDMR Shareholding
26th Apr 20181:12 pmRNSResult of AGM
26th Apr 20187:00 amRNSAGM Statement
29th Mar 20182:09 pmRNSDirector/PDMR Shareholding
27th Mar 20184:52 pmRNSHolding(s) in Company
26th Mar 20187:00 amRNSContract Win
21st Mar 20187:01 amRNSAnnual Report and Notice of AGM
21st Mar 20187:00 amRNSDirectorate Change
20th Feb 20187:00 amRNSFinal Results
23rd Jan 20187:00 amRNSNotification of Final Results
8th Jan 20183:19 pmRNSElectronic Communication with Shareholders
4th Jan 20181:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.